In particular, in Duchenne Muscular Dystrophy, an X-linked pathology related to mutation of Dystrophin (DMD), HDAC inhibitors have revealed beneficial effects [158]. This evidence concerns the gene HDAC9 and Duchenne muscular dystrophy.